Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 06, 2007. The report details a specific corporate action regarding the repurchase of the company's own shares in accordance with shareholder authority granted at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on share capital movements.
- Shares Repurchased: 1,200,000 Ordinary shares of 25 pence each.
- Repurchase Price: 1,214.62 pence per share.
- Treasury Shares Held: 478,189,158 shares (representing 8.62% of total voting rights).
- Shares in Issue: 5,547,031,425 shares (excluding Treasury shares).
Material Changes
The primary material change is the increase in the company's Treasury shareholding following the November 06, 2007 transaction. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities. The transaction was executed in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares in issue (5,547,031,425) for calculating disclosure thresholds under FSA rules.
- Confirm the updated Treasury share count (478,189,158) and its percentage of voting rights (8.62%).
- Note that this filing does not contain financial performance results; refer to Form 20-F for comprehensive financial data.